Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 05, 2017 08:00 ET | Source: Alcobra Ltd.

Alcobra Provides Update on Request for Extraordinary General Meeting

Brosh Capital’s Request Does Not Comply With Alcobra’s Articles of Association Company Addresses Brosh Capital’s Misinformed Views TEL AVIV, Israel, April 05, 2017 (GLOBE NEWSWIRE) --...
April 05, 2017 08:00 ET | Source: Endocyte, Inc.

Endocyte Presents Data at AACR Identifying Multiple Methods for Managing Severe Side Effects Resulting from CAR T-Cell Treatment

- Late-breaking poster demonstrates that Endocyte’s bi-specific adaptor molecules can mitigate or eliminate cytokine storms - - Potential to meaningfully improve the safety and tolerability of CAR...
April 05, 2017 07:43 ET | Source: Abeona Therapeutics Inc

Abeona Announces Rare Disease Gene Therapy Symposium with the New York Academy of Sciences

Company CEO to Co-Chair Symposium being held on April 11th in NYC NEW YORK and CLEVELAND, April 05, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage...
April 05, 2017 07:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Participate at Upcoming April Conferences

BASKING RIDGE, N.J., April 05, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company with a select therapeutic development...
April 05, 2017 07:05 ET | Source: Myriad Genetics, Inc.

Pivotal Study Results for Myriad’s myPath® Melanoma Test Highlighted In Two Additional Scientific Publications

SALT LAKE CITY, April 05, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it has published the third...
April 05, 2017 05:30 ET | Source: Global Market Insights, Inc

Guidewires Market worth over $2.5bn by 2023: Global Market Insights, Inc.

Ocean View, Delaware, April 05, 2017 (GLOBE NEWSWIRE) -- The healthcare research report “Guidewires Market Size by Product (Coronary, Peripheral, Neurovascular, Urology), Industry Analysis Report,...
April 05, 2017 02:00 ET | Source: OSE Immunotherapeutics

OSE Immunotherapeutics Presented New Data at AACR* Annual Meeting 2017 on OSE-172 (Effi-DEM), Company’s Checkpoint Inhibitor Blocking Suppressive Myeloid Cells and Inducing Antitumoral Potent T Memory Response

NANTES, France, April 05, 2017 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173) (Mnémo:OSE) announced today that the Company presented significant results at the AACR* meeting in...
April 05, 2017 01:50 ET | Source: Zion Market Research

Global Hepatitis C Drug Market will reach USD 33.50 Billion by 2022: Zion Market Research

Sarasota, FL, April 05, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Hepatitis C Drug Market for Hospitals, Private labs, Physician offices, Public health labs...
April 04, 2017 17:15 ET | Source: Osiris Therapeutics, Inc.

Osiris Therapeutics to Present 29 Advanced Clinical and Scientific Abstracts, Including a Late-Breaking Abstract on its New Ambient Viable Tissue Preservation Technology

COLUMBIA, Md., April 04, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (Pink Sheets:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care,...
April 04, 2017 16:10 ET | Source: Novelion Therapeutics, Inc.

Metreleptin and Lipodystrophy Data Presented at the Annual Meeting of the Endocrine Society

VANCOUVER, British Columbia & CAMBRIDGE, Mass., April 04, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new...